The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea / 예방의학회지
Journal of Preventive Medicine and Public Health
;
: 180-187, 2015.
Article
in English
| WPRIM
| ID: wpr-211247
ABSTRACT
OBJECTIVES:
Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea.METHODS:
We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers' costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death.RESULTS:
In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively.CONCLUSIONS:
We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Risk
/
Cost of Illness
/
Metabolic Syndrome
/
Republic of Korea
/
Insurance Claim Reporting
/
Neoplasms
Type of study:
Etiology study
/
Health economic evaluation
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
Country/Region as subject:
Asia
Language:
English
Journal:
Journal of Preventive Medicine and Public Health
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS